Gedea Biotech develops antibiotic-free and safe local treatments of bacterial and fungal infections. Gedea Biotech’s substance, GA101, is a natural substance that has always been part of our environment and is approved as a food additive. It acts by a novel mechanism that prevents and treats infection in depth by inhibiting the formation of biofilm. Due to the novel mode of action it has a reduced risk of inducing treatment resistance. The first product will be a slow-release pessary for treatment and prevention of vaginal fungal infections to be market launched in 2019/2020 as an OTC.